Evidence map›Paper›PMID 29721579›Full record

ReviewPsychopharmacology2018

GABA

Mairi Koulentaki, Elias Kouroumalis

Abstract readReview
PubMed Publisher
In one paragraph

Review in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. GABAergic compounds for the treatment of alcohol use disorder.International review of neurobiology · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Mairi KoulentakiAlcohology Research Laboratory, Medical School, University of Crete, 71500, Heraklion, Crete, Greece.
Elias KouroumalisDepartment of Gastroenterology, University Hospital Heraklion, 71500, Heraklion, Crete, Greece. kouroumi@uoc.gr.ORCID http://orcid.org/0000-0002-6875-906X
University Hospital of Heraklion · GRUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcohol use disorder (AUD) is a chronic, relapsing, neuro-psychiatric illness of high prevalence and with a serious public health impact worldwide. It is complex and polygenic, with a heritability of about 50%, and influenced by environmental causal heterogeneity. Risk factors associated with its etiology have a genetic component. GABA (γ-aminobutyric acid) is a major inhibitory neurotransmitter in mammalian brain. GABA

Indexed as

AlcoholismAnimalsBraingamma-Aminobutyric AcidGenome-Wide Association StudyGenotypeHumansPolymorphism, Single NucleotideReceptors, GABA-Agamma-Aminobutyric AcidReceptors, GABA-AAlcoholConsumptionDependenceGABAGABA receptorsLinkage

Identifiers

PMID29721579
OpenAlexW2800493476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.